MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway

Published:2017-01 Issue: Volume:596 Page:110-118
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Shen Hongyu,Wang Dandan,Li Liangpeng,Yang Sujin,Chen Xiu,Zhou Siying,Zhong Shanliang,Zhao Jianhua,Tang Jinhai

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

National key clinical specialist construction Programs of China

Major Program of Natural Science Foundation of Jiangsu Province

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference47 articles.

1. Pathways to breast cancer recurrence;Ahmad;ISRN Oncol.,2013

2. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity;Armoni;J. Biol. Chem.,2006

3. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics;Bar;PLoS One,2010

4. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer;Binkley;Cancer,2012

5. PTEN modulators: a patent review;Boosani;Expert Opin. Ther. Pat.,2013

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view;Functional & Integrative Genomics;2024-09-02

2. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis;International Journal of Molecular Sciences;2023-11-06

3. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10

4. Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer;Functional & Integrative Genomics;2023-07-11

5. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer;International Journal of Molecular Sciences;2023-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3